Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

ClinicalTrials.gov ID: NCT04947553

Public ClinicalTrials.gov record NCT04947553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Dementia of the Alzheimer's Type

Study identification

NCT ID
NCT04947553
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
456 participants

Conditions and interventions

Interventions

  • AXS-05 (dextromethorphan-bupropion) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
65 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2021
Primary completion
Dec 2, 2024
Completion
Dec 20, 2024
Last update posted
Dec 7, 2025

2021 – 2024

United States locations

U.S. sites
45
U.S. states
13
U.S. cities
38
Facility City State ZIP Site status
Clinical Research Site Peoria Arizona 83581
Clinical Research Site Tempe Arizona 85282
Clinical Research Site Long Beach California 90807
Clinical Research Site Santa Ana California 92705
Clinical Research Site Temecula California 92591
Clinical Research Site Walnut Creek California 94596
Clinical Research Site Bonita Springs Florida 34134
Clinical Research Site Brandon Florida 33511
Clinical Research Site Coral Springs Florida 33067
Clinical Research Site Greenacres City Florida 33467
Clinical Research Site Hialeah Florida 33012
Clinical Research Site Hollywood Florida 33024
Clinical Research Site Kissimmee Florida 34741
Clinical Research Site Lake City Florida 32055
Clinical Research Site Miami Florida 33126
Clinical Research Site Miami Florida 33135
Clinical Research Site Miami Florida 33145
Clinical Research Site Miami Florida 33155
Clinical Research Site Miami Florida 33165
Clinical Research Site Miami Florida 33173
Clinical Research Site Miami Florida 33175
Clinical Research Site Miami Gardens Florida 33014
Clinical Research Site Miami Lakes Florida 33014
Clinical Research Site Orlando Florida 32807
Clinical Research Site Pembroke Pines Florida 33025
Clinical Research Site Tampa Florida 33614
Clinical Research Site Tampa Florida 33634
Clinical Research Site Trinity Florida 34655
Clinical Research Site Columbus Georgia 31909
Clinical Research Site Wichita Kansas 67214
Clinical Research Site Braintree Massachusetts 02184
Clinical Research Site Flint Michigan 48532
Clinical Research Site Rochester Hills Michigan 48307
Clinical Research Site Chesterfield Missouri 63005
Clinical Research Site Toms River New Jersey 08755
Clinical Research Site Brooklyn New York 11229
Clinical Research Site New Windsor New York 12553
Clinical Research Site Staten Island New York 10314
Clinical Research Site Charlotte North Carolina 28211
Clinical Research Site Hickory North Carolina 28601
Clinical Research Site Austin Texas 78737
Clinical Research Site Cypress Texas 77429
Clinical Research Site Mesquite Texas 75149
Clinical Research Site Sugar Land Texas 77478
Clinical Research Site Arlington Virginia 22205

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04947553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04947553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →